In these transgenic mice, tamoxifen inducible expression of the human H-ras protein fused with the G525R mutant murine estrogen receptor ligand binding domain, is directed to epidermis by the human keratin 14 promoter.
Paul Khavari, Stanford University
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inducible, Constitutively active, Inserted expressed sequence, Humanized sequence) |
Mice hemizygous for this "K14-ER:Ras" transgene are viable and fertile, with expression of the ER:Ras fusion protein (constitutively active G12V mutant form of the catalytic domain of human H-ras (H-rasV12) fused at its amino terminal with the G525R mutant murine estrogen receptor ligand binding domain (ERTM)) directed to epidermis by the human keratin 14 promoter. Because of the ERTM region of the fusion protein, ER:Ras is restricted to the cytoplasm and the biochemical activity of the ER:Ras fusion gene can be induced following tamoxifen administration. For example, prolonged (4 weeks) induction of human H-RasG12V activity promotes the undifferentiated, proliferative phenotypic characteristics observed in epidermal cancer; including hyperplasia, increased mitotic index, decreased expression of differentiation markers and increased expression of beta-1 and beta-4 integrin subunits. H-RasG12V-induced skin abnormalities were entirely reversed within one month after 4OHT cessation. These mice have a similar 4OHT-inducible skin phenotype as the transgenic mice expressing human Raf-1[DD] (Stock No. 006661) or human Mek1R4F (Stock No. 006822), and may be useful in studies of the Ras/Raf/MEK/ERK cell proliferation and differentiation pathway, as well as to elucidate cellular events preceding skin cancer cell transformation.
The G525R mutant murine estrogen receptor ligand binding domain (ERTM) does not bind its natural ligand (17β-estradiol) at physiological concentrations; but will bind the synthetic estrogen receptor ligands 4-hydroxytamoxifen (OHT or tamoxifen) and, with lesser sensitivity, ICI 182780. Restricted to the cytoplasm, ERTM fusion proteins can only gain access to the nuclear compartment after exposure to tamoxifen. To counteract the mixed estrogen agonist effects of tamoxifen injections, which can result in late fetal abortions in pregnant mice, progesterone may be coadministered.
The K14-ER:Ras transgene was designed with a 2075-bp human keratin 14 promoter sequence upstream of the constitutively active G12V mutant form of the catalytic domain of human H-ras (H-rasV12) fused at its amino terminal with the G525R mutant murine estrogen receptor ligand binding domain (ERTM), which renders transgene expression tamoxifen (4OHT) inducible yet estrogen insensitive. This transgene was injected into the pronuclei of C57BL/6 embryos and chimeric founders were established. Mice were then backcrossed to "129/SvEv" mice for 5 generations prior to arrival at The Jackson Laboratory.
Expressed Gene | HRAS, HRas proto-oncogene, GTPase, human |
---|---|
Site of Expression |
Allele Name | transgene insertion 1, Paul A Khavari |
---|---|
Allele Type | Transgenic (Inducible, Constitutively active, Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | K14-ER:Ras |
Gene Symbol and Name | Tg(KRT14-Esr1/HRAS)1Pkha, transgene insertion 1, Paul A Khavari |
Gene Synonym(s) | |
Promoter | KRT14, keratin 14, human |
Expressed Gene | HRAS, HRas proto-oncogene, GTPase, human |
Strain of Origin | C57BL/6 |
Chromosome | UN |
General Note | Multiple mouse lines were generated, with varying transgene copy numbers and expression levels of the fusion protein. Lines were identified only as H, M, and L for high, medium and low copy number, respectively. |
Molecular Note | The transgene contains a 2075-bp human keratin 14 promoter construct driving expression of a cDNA that encodes a fusion protein comprising a constitutively active mutant form of the catalytic domain of human HRAS, in which glycine at amino acid position 12 is replaced by arginine (G12V), joined at its amino terminal to a mutant mouse estrogen receptor ligand-binding domain in which replacement of glycine by arginine at amino acid position 525 (G525R, "ERTM") renders the fusion protein's activity inducible by 4-hydroxytamoxifen, but unresponsive to natural estrogen (17beta-estradiol). |
Mutations Made By | Paul Khavari, Stanford University |
When maintaining a live colony, hemizygotes are bred to wildtype siblings or to inbred 129S1/SvImJ (Stock No. 002448) mice.
When using the K14-ER:Ras mouse strain in a publication, please cite the originating article(s) and include JAX stock #006403 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non-carrier for Tg(KRT14-Esr1/HRAS)1Pkha |
Frozen Mouse Embryo | 129S.B6-Tg(KRT14-Esr1/HRAS)1Pkha/J | $2595.00 |
Frozen Mouse Embryo | 129S.B6-Tg(KRT14-Esr1/HRAS)1Pkha/J | $2595.00 |
Frozen Mouse Embryo | 129S.B6-Tg(KRT14-Esr1/HRAS)1Pkha/J | $3373.50 |
Frozen Mouse Embryo | 129S.B6-Tg(KRT14-Esr1/HRAS)1Pkha/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.